Kitonail (Ciclopirox)

Ciclopirox works by inhibiting the synthesis of fungal sterols, which are essential components of the cell membrane. This disruption compromises membrane integrity, leading to leakage of cellular contents and ultimately causing fungal cell death.

The dosing regimen for Kitonail is determined by the prescribing healthcare professional based on the severity of the infection and patient-specific factors. Patients should follow the prescriber’s instructions and the product labeling for application frequency and duration.

Safety of ciclopirox in pregnancy or while breastfeeding has not been fully established. Women who are pregnant, planning to become pregnant, or nursing should discuss potential risks and benefits with their healthcare provider before using Kitonail.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details, and necessary import documentation.

Kitonail’s active ingredient, ciclopirox, offers a broad spectrum of antifungal activity and is applied topically, avoiding systemic exposure. Compared with oral antifungals, it has a lower risk of systemic side effects but may require longer treatment duration for complete cure.

Kitonail should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture and direct sunlight, and ensure the container is tightly closed when not in use to maintain product stability.

Kitonail is applied directly to the affected nail and surrounding skin. The prescribed amount is spread evenly over the nail surface, usually once daily, after cleaning and drying the nail. Patients should follow the specific application instructions provided by their healthcare professional.

Serious risks, though rare, include severe allergic reactions such as swelling, hives, or difficulty breathing, as well as rare skin conditions like Stevens‑Johnson syndrome. If any signs of a serious reaction occur, discontinue use immediately and seek medical attention.

Kitonail should not be used by individuals with known hypersensitivity to ciclopirox or any component of the formulation. It is also contraindicated on broken, inflamed, or infected skin, and should be avoided in patients who have experienced severe allergic reactions to similar topical antifungals.